Conference Coverage

Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Coming from the 2019 annual CHEST conference in New Orleans, Dr. Nicola Hanania joins Dr. Neil Freedman to discuss the advances in the diagnosis and treatment of COPD as well as the updated GOLD guidelines that were covered at the conference.

Coming from the 2019 annual CHEST conference in New Orleans, Dr. Nicola Hanania joins Dr. Neil Freedman to discuss the advances in the diagnosis and treatment of COPD as well as the updated GOLD guidelines that were covered at the conference.

Despite recent advances in management, many patients still experience uncontrolled or poorly controlled asthma. To keep you up to date on those emerging treatment options, this expert discussion will review patient- and practice-focused data presented during ACAAI 2019.

At the 2019 CHEST annual conference, Dr. Anoop Nambiar got a chance to catch up with Dr. Joshua Mooney, who highlighted the conference’s key takeaways on interstitial lung disease, like recently developed screening tools, lung transplant technologies, self-care strategies for patients, and more.

Along with strategies and the latest treatment approaches, Drs. Nambiar and Mooney will discuss clinically relevant suggestions that healthcare providers can start to use today in patients with ILD.

This episode is supported in part by an unrestricted/independent medical educational grants from the following: Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.

Recorded live at the 2019 annual CHEST conference in New Orleans, Dr. Monica Kraft joins Dr. Sandhya Khurana to talk about how the new available biologics are going to fit into the severe asthma treatment landscape along with other highlights from the conference.

This episode is supported in part by an unrestricted/independent medical educational grants from the following: Genentech, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation.

Drs. Natalie West and Allison Lambert join Dr. Kristina Montemayor on the floor of the 2019 CHEST annual conference to talk about the sweat chloride test, CFTR modulator therapies, and other emerging strategies for diagnosing and treating patients with cystic fibrosis.

In this episode, Drs. West, Lambert, and Montemayor will share what clinicians should do to improve our patients with cystic fibrosis.

This episode is supported in part by an unrestricted/independent medical educational grants from the following: Chiesi USA, Inc., Mylan Specialty, and Vertex Pharmaceuticals Incorporated.

Recorded live at the 2019 annual CHEST conference in New Orleans, Dr. Monica Kraft joins Dr. Sandhya Khurana to talk about how the new available biologics are going to fit into the severe asthma treatment landscape along with other highlights from the conference.

This episode is supported in part by an unrestricted/independent medical educational grants from the following: Genentech, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation.

Drs. Natalie West and Allison Lambert join Dr. Kristina Montemayor on the floor of the 2019 CHEST annual conference to talk about the sweat chloride test, CFTR modulator therapies, and other emerging strategies for diagnosing and treating patients with cystic fibrosis.

In this episode, Drs. West, Lambert, and Montemayor will share what clinicians should do to improve our patients with cystic fibrosis.

This episode is supported in part by an unrestricted/independent medical educational grants from the following: Chiesi USA, Inc., Mylan Specialty, and Vertex Pharmaceuticals Incorporated.

At the 2019 CHEST annual conference, Dr. Anoop Nambiar got a chance to catch up with Dr. Joshua Mooney, who highlighted the conference’s key takeaways on interstitial lung disease, like recently developed screening tools, lung transplant technologies, self-care strategies for patients, and more.

Along with strategies and the latest treatment approaches, Drs. Nambiar and Mooney will discuss clinically relevant suggestions that healthcare providers can start to use today in patients with ILD.

This episode is supported in part by an unrestricted/independent medical educational grants from the following: Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.